AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Nissui Pharmaceutical Co., Ltd.
  3. Financials
  4. Capital expenditures

Nissui Pharmaceutical Co., Ltd.【JP:E00971】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
Mar 31, 2022-49-59.50%
Mar 31, 2021-121-92.16%
Mar 31, 2020-1,544+376.54%
Mar 31, 2019-324-36.47%
Mar 31, 2018-510+11.89%
Mar 31, 2017-456+3.62%
Mar 31, 2016-440+134.68%
Mar 31, 2015-187

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)